{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T05:43:39Z","timestamp":1676439819689},"reference-count":3,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1111\/bjd.15033","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T12:50:21Z","timestamp":1482238221000},"page":"1135-1136","source":"Crossref","is-referenced-by-count":1,"title":["Epidermal growth factor receptor inhibitor-associated rash prevented by oral tetracyclines"],"prefix":"10.1093","volume":"175","author":[{"given":"R.","family":"van Doorn","sequence":"first","affiliation":[{"name":"Department of Dermatology; Leiden University Medical Center; Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J.","family":"van Zuuren","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Leiden University Medical Center; Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,12,20]]},"reference":[{"issue":"Suppl. 5","key":"10.1111\/bjd.15033-BIB0001|bjd15033-cit-0001","first-page":"4","article-title":"Clinical presentation and pathophysiology of EGFRI dermatologic toxicities","volume":"21","author":"Mitchell","year":"2007","journal-title":"Oncology"},{"key":"10.1111\/bjd.15033-BIB0002|bjd15033-cit-0002","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/bjd.14756","article-title":"Antibiotic prophylaxis for skin toxicity induced by antiepidermal growth factor receptor agents: a systematic review and meta-analysis","volume":"175","author":"Petrelli","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15033-BIB0003|bjd15033-cit-0003","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jaad.2016.01.019","article-title":"Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: a randomized, open-label trial","volume":"74","author":"Deplanque","year":"2016","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15033","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15033","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.15033\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:23:28Z","timestamp":1676384608000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/175\/6\/1135\/6698458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":3,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.15033","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}